Clinical study examines Amalakibeejadi Yog's impact on dysfunctional uterine bleeding in patients, indicating significant therapeutic benefits.
Background: Dysfunctional Uterine Bleeding (DUB) is defined as abnormal uterine bleeding without structural pathology, pregnancy, or systemic illness. It commonly affects women of reproductive age and can cause significant morbidity. In Ayurveda, DUB is comparable to Asrigdara, characterized by excessive and prolonged menstrual bleeding due to vitiated Pitta and Vatadosha. Ayurvedic management emphasizes Pitta-pacifying and hemostatic therapies. Materials and Methods: A single-arm clinical study was conducted on 30 female patients aged 18–50 years, diagnosed with Asrigdara, selected from the OPD/IPD of the Department of Striroga and PrasutiTantra. Patients were assessed before and after treatment for PBAC score, duration of bleeding, cycle interval, and associated symptoms. Laboratory investigations (Hb%, CBC, BT, CT) were performed. Data were analyzed using paired t-test, with p < 0.05 considered significant. Results: A total of 30 patients diagnosed with Asrigdara were enrolled in the study after fulfilling the inclusion and exclusion criteria. All patients completed the treatment and were assessed for clinical outcomes. The therapeutic response to the trial drug was evaluated based on changes in clinical symptoms of Asrigdara before and after treatment. The severity of symptoms was scored, and the percentage of improvement was calculated. Conclusions: Amalakibeejadi Yog is quite effective, well-tolerable by patientsand safe in managing bleeding in DUB.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: